Variable indoleamine 2,3‐dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy

Immune checkpoint inhibitors have improved the prognosis of advanced melanoma. Although anti–programmed death ligand‐1 (PD‐L1) is a well‐studied biomarker for response to anti–programmed death‐1 PD‐1 therapy in melanoma, its clinical relevance remains unclear. It has been established that the high e...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Sci
Prif Awduron: Iga, Natsuko, Otsuka, Atsushi, Hirata, Masahiro, Kataoka, Tatsuki R., Irie, Hiroyuki, Nakashima, Chisa, Matsushita, Shigeto, Uchi, Hiroshi, Yamamoto, Yuki, Funakoshi, Takeru, Fujisawa, Yasuhiro, Yoshino, Koji, Fujimura, Taku, Hata, Hiroo, Ishida, Yoshihiro, Kabashima, Kenji
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2019
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6824999/
https://ncbi.nlm.nih.gov/pubmed/31509303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14195
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg